🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

9 recruiting trials

for Group 3 Pulmonary Hypertension

Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) NCT07179380Phase 3186 sites📍 Phoenix📍 Fresno📍 Los Angeles Insmed Incorporated · Tests: Treprostinil Palmitil Inhalation Powder, Placebo Nailfold Capillaroscopy in PH NCT07768644n/a1 site📍 Clydebank University of Glasgow · Tests: Standard of Care therapy Pulmonary Hypertension SOLAR NCT04778046Phase 21 site📍 Durham Bastiaan Driehuys · Tests: Hyperpolarized 129Xe A Trial of "APL-9796'' in Adults With Pulmonary Hypertension NCT06846554Phase 26 sites📍 London📍 Bath📍 Cambridge Apollo Therapeutics Ltd · Tests: APL-9796, APL-9796 Exploration of Metabolome in Patients With Interstitial Lung Disease and Pulmonary Hypertension With or Without Specific Pulmonary Hypertension Treatment NCT07254338n/a1 site📍 Bron Hospices Civils de Lyon · Tests: Blood sampling for metabolomic profiling, Urine sampling for metabolomic profiling Study to Evaluate Safety and Efficacy of Mirivadelgat in PH-ILD (Windward) NCT06475781Phase 211 sites📍 Banja Luka📍 Sarajevo📍 Hualien City Foresee Pharmaceuticals Co., Ltd. · Tests: Mirivadelgat, placebo DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) NCT06388421n/a71 sites📍 Birmingham📍 Phoenix📍 Los Angeles United Therapeutics · Tests: Prospective study assessments A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD NCT07285655Phase 344 sites📍 Phoenix📍 Scottsdale📍 Los Angeles Liquidia Technologies, Inc. · Tests: L606, Placebo A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH) NCT07481981Phase 339 sites📍 Los Angeles📍 Santa Barbara📍 Torrance Insmed Incorporated · Tests: Treprostinil Palmitil Inhalation Powder, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy